Metraipolis › archive › dc_8be024c3b850
Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study — Europe PMC PMID:36532727
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/36532727
- DOI
- 10.3389/fphar.2022.1054644
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T16:05:35.068Z
- SHA-256 of the archived text
60c094802ec3abd6448bfbdb44d876f8b360735dc9ce018940dac6c9a6c49d97- Stable URL of this page
https://metraipolis.com/documento/dc_8be024c3b850
How to cite
Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study — Europe PMC PMID:36532727 — Europe PMC (en), https://europepmc.org/article/MED/36532727 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8be024c3b850 (Metraipolis archive dc_8be024c3b850, sha256 60c094802ec3abd6448bfbdb44d876f8b360735dc9ce018940dac6c9a6c49d97)
BibTeX
@misc{dc8be024c3b850,
title = {Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study — Europe PMC PMID:36532727},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/36532727},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8be024c3b850; sha256 60c094802ec3abd6448bfbdb44d876f8b360735dc9ce018940dac6c9a6c49d97},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36532727. Agents can read the archived copy with the MCP tool read_document.